Transcriptomics

Dataset Information

0

Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids


ABSTRACT: Women with obesity-driven type 2 diabetes (T2D) face worse breast cancer outcomes, yet metabolic status does not fully inform current standards of care. We previously identified plasma exosomes as key drivers of tumor progression; however, their effect on immune cells within the tumor microenvironment (TME) remains unclear. Using a novel patient-derived organoid (PDO) system that preserves native tumor-infiltrating lymphocytes (TILs), we show that T2D plasma exosomes induce a 13.6-fold expansion of immunosuppressive TILs relative to nondiabetic controls. This immune dysfunction may promote micrometastatic survival and resistance to checkpoint blockade, a known issue in T2D cancer patients. Tumor-intrinsic analysis revealed a 1.5-fold increase in intratumoral heterogeneity and 2.3-fold upregulation of aggressive signaling networks. These findings reveal how T2D-associated metabolic dysregulation alters tumor–immune crosstalk through previously underappreciated exosomal signaling, impairing antitumor immunity and accelerating progression. Understanding these dynamics could inform tailored therapies for this high-risk, underserved patient population.

ORGANISM(S): Homo sapiens

PROVIDER: GSE302054 | GEO | 2025/07/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-12-31 | E-GEOD-42824 | biostudies-arrayexpress
2022-03-24 | GSE198956 | GEO
2023-05-09 | PXD024434 | Pride
2023-05-27 | GSE218526 | GEO
2013-02-07 | E-GEOD-27928 | biostudies-arrayexpress
2025-01-23 | GSE280002 | GEO
2023-02-20 | PXD036811 | Pride
2022-06-01 | GSE188330 | GEO
2016-11-03 | E-MTAB-4166 | biostudies-arrayexpress
2013-02-07 | GSE27928 | GEO